Anhui Anke Biotechnology Financials

Market Capitalization CN¥16.78 Billion as of Jan. 1, 2026

Valuations Metrics as of Jan. 3, 2026

Trailing PE	23.93
Forward PE	13.48
Price to Sales TTM	CN¥6.21
Price to Book MRQ	CN¥3.84
Enterprise to Revenue	5.78
Enterprise to EBITDA	18.44

Financial Reports as of Jun. 30, 2025

Financials

Fiscal Year Ends	2024-12-31
Most Recent Quarter	2025-06-30
Profit Margin	25.95%
Operating Margin	34.10%
Return on Assets TTM	8.88%
Return on Equity TTM	16.01%

Income Statement

Revenue TTM	CN¥2,577,352,704
Revenue per Share TTM	CN¥1.55
Quarterly Revenue Growth	7.70%
Gross Profit TTM	CN¥1,952,199,680
EBITDA	CN¥759,633,943
Net Income to Common TTM	CN¥668,711,680
Diluted EPS TTM	CN¥0.40
Quarterly Earnings Growth YoY	6.60%

Balance Sheet

Total Cash MRQ	CN¥1,310,390,400
Total Cash per Share MRQ	CN¥0.78
Total Debt MRQ	CN¥
Total Debt to Equity MRQ	0.71
Current Ratio MRQ	3.78
Book Value per Share MRQ	CN¥2.49

Cash Flow

Operating Cash Flow TTM	CN¥820,305,728
Levered Free Cash Flow TTM	CN¥432,099,744

300009 Stock Info as of Jan. 3, 2026

Stock Statistics

Shares Outstanding	1,672,521,258
Float Shares	1,035,557,511
Avg 10 Volume	13,033,889
Avg 30 Volume	None
Shares Short	None
Short Ratio
Short % of Shares	%
% Held by Insiders	37.88%
% Held by Institutions	5.39%

Stock Price Summary

Beta	0.51
Fifty Two Week Low	CN¥7.38
Fifty Two Week High	CN¥13.06
Fifty Two Week Change	11.18%
Day 50 MA	CN¥10.14
Day 200 MA	CN¥9.69

Dividends and Splits

Forward Annual Dividend Rate	CN¥0.60
Forward Annual Dividend Yield	6.27%
Trailing Annual Dividend Rate	CN¥0.15
Trailing Annual Dividend Yield	1.57%
Payout Ratio	62.50%
Dividend Date
Ex Dividend Date	2025-05-23
Last Split Factor
Last Split Date	2021-05-14